Anti-CCL5 Recombinant Antibody Products

Loading...

Anti-CCL5 Products

+ Filter
Loading...
View More Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs is a leader in immuno-oncology and chronic inflammation research, providing top-tier anti-CCL5 recombinant antibodies. The pro-inflammatory chemokine C-C Motif Chemokine Ligand 5 (CCL5), also known as RANTES, is a powerful pleiotropic chemokine that orchestrates immune cell trafficking in both health and disease. Our high-quality anti-CCL5 antibodies provide key insights into its dual roles in promoting anti-viral immunity and tumor progression.

CCL5: The Pleiotropic Chemokine RANTES

C-C Motif Chemokine Ligand 5 (CCL5) is better known as RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted). It is a pro-inflammatory chemokine that is produced by a broad range of cells including T-cells, platelets, and tumor cells. As a strong chemoattractant for T-cells, monocytes, eosinophils, and basophils, it acts by binding to its cognate receptors (CCR1, CCR3, and CCR5). While it is critical for recruitment of effector T-cells to the site of viral infection, in the setting of cancer its roles are more diverse and complex. In the tumor microenvironment (TME), it can contribute to recruitment of suppressive cells such as Tregs, and it can directly promote tumor cell proliferation and invasion. For this reason, CCL5 is an attractive therapeutic target for immunotherapy drug discovery.

Alternative Names

CCL5; C-C motif chemokine ligand 5; SISd; eoCP; SCYA5; RANTES; TCP228; D17S136E; SIS-delta

Background

CCL5 (C-C Motif Chemokine Ligand 5) is a Protein Coding gene. Diseases associated with CCL5 include Ulcer Of Lower Limbs and Periapical Granuloma. Among its related pathways are PEDF Induced Signaling and Toll-like receptor signaling pathway. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and chemokine activity. An important paralog of this gene is CCL3L3.

Protein class

Cancer-related genes, Human disease related genes, Plasma proteins

Predicted location

Membrane, Secreted (different isoforms)

Single cell type specificity

Group enriched (NK-cells, dendritic cells, T-cells)

Immune cell specificity

Immune cell enhanced (memory CD8 T-cell, gdT-cell)

Cell line specificity

Cell line enhanced (HL-60, NB-4, THP-1, U-937)

Interaction

Homo and heterooligomers with other chemokines. Interacts with the brown dog tick evasin-4.

Molecular function

Cytokine

More Types Infomation

Anti-CCL5 rAb Products

Our anti-CCL5 recombinant antibodies are optimized for high-affinity and potent neutralization, and they are extensively validated to ensure that they will accurately detect and potently neutralize the biological activity of human CCL5. Optimized for use in assays like ELISA and IHC to map its expression in the TME as well as for functional neutralization of T-cell migration, our rAbs are designed to be top-of-class tools for both basic immunology research and for drug discovery.

Table 1. Featured anti-CCL5 recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
NEUT-231CQ Mouse Anti-CCL5 Recombinant Antibody (clone CBL636) Canine Mouse IgG2b Neut
NEUT-242CQ Mouse Anti-CCL5 Recombinant Antibody (clone 5B3-D5) Human Mouse IgG2b ELISA, Neut, WB
HPAB-0380LY Human Anti-CCL5 Recombinant Antibody (clone 1D9) Human Human IgG1 ELISA, Inhib, FC, IF

Customer Reviews

Excellent
P**ce
Human Anti-CCL5 Recombinant Antibody (clone 1D9)
The quality of Creative Biolabs’ reagents is outstanding. We have used their anti-CCL5 antibody and it has provided consistent, high-quality data throughout our project to develop novel cancer therapies.
11/Jun/2023

rAb Production

Creative Biolabs has advanced production technologies to help speed progress in immuno-oncology. Our anti-CCL5 recombinant antibodies are optimized for high-affinity and potent neutralizing capacity, making them ideal for dissecting and targeting the tumor microenvironment.

Featured Anti-CCL5 Recombinant Antibody Production PlatformsFig.1 Milligram-scale. (Creative Biolabs Original)
Fig.1 Milligram-scale anti-CCL5 recombinant antibody production.

Fig.2 Gram-scale. (Creative Biolabs Original)Fig.2 Gram-scale anti-CCL5 recombinant antibody production.

rAb Modalities

Creative Biolabs is committed to supporting the research community with flexible and innovative tools for your research. Our anti-CCL5 recombinant antibodies are available in a variety of customizable modalities, including full-length IgGs for in vivo blocking studies, as well as for ELISA as matched pairs.

Fig.3 CCL5 antibody production and modalities. (Creative Biolabs Original)Fig.3 Full-length anti-CCL5 recombinant antibody production and modalities.

CCL5-Targeted Drug Information

Table 2. Public drug targeting CCL5.

Company Research Phase Classification Condition
Bristol Myers Squibb Approved (for HIV), Phase 3 (for Cancer) Monoclonal Antibody (targets CCR5) HIV, Metastatic Triple-Negative Breast Cancer
ChemoCentryx Phase 2 (Terminated) Small Molecule (CCR2/CCR5 Antagonist) Pancreatic Cancer
HUMABS BioMed (Vir) Preclinical Monoclonal Antibody HIV

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

Accelerate your research with Creative Biolabs’ superior anti-CCL5 recombinant antibodies. High specificity and functional validation define our portfolio and provide the tools you need for both basic research and therapeutic development. Let us be a trusted partner to help you do your important work. Contact our specialists today.

Go to compare

Go to compare